Clinical Trial Update: A Research Study Looking at the Safety of Multiple Doses of ZP8396 and How it Works in the Body of Healthy Participants [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the safety and pharmacokinetics of multiple doses of ZP8396 in healthy volunteers who are overweight or obese.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• ZP8396

Snippet

Sponsor: Zealand Pharma | Conditions: Overweight, Healthy Volunteers | Phase 1 | Status: COMPLETED